Skip to main content
Erschienen in: Zeitschrift für Rheumatologie 7/2013

01.09.2013 | Originalien

Impfung bei erwachsenen Patienten mit chronisch entzündlichen rheumatischen Erkrankungen

verfasst von: Dr. S. Goldacker, A.M. Gause, K. Warnatz, Kommission Pharmakotherapie der DGRh

Erschienen in: Zeitschrift für Rheumatologie | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Zusammenfassung

Bei Patienten mit chronisch entzündlich rheumatischen Erkrankungen besteht häufig eine intrinsische und therapiebedingte erhöhte Infektanfälligkeit, die wesentlich zu Morbidität und Mortalität der Patienten beiträgt. Ein großer Anteil dieser Infektionen ist impfpräventabel. Aus diesem Grund empfahl die Ständige Impfkommission (STIKO) 2005 neben den Regelimpfungen zusätzlich altersunabhängig bei Patienten mit Immunsuppression die Impfung gegen Pneumokokken, Influenza sowie gegen Haemophilus influenzae b und Meningokokken. Jeder Patient sollte deshalb vor der Einleitung einer immunsuppressiven Therapie über eine mögliche Zunahme der Infektneigung und die empfohlene Impfprävention aufgeklärt werden.
Literatur
1.
Zurück zum Zitat Luis A de, Pigrau C, Pahissa A et al (1990) Infections in 96 cases of systemic lupus erythematosus. Med Clin (Barc) 94(16):607–610 Luis A de, Pigrau C, Pahissa A et al (1990) Infections in 96 cases of systemic lupus erythematosus. Med Clin (Barc) 94(16):607–610
2.
Zurück zum Zitat Massardo L, Martinez ME, Baro M et al (1991) Infections in systemic lupus erythematosus. Rev Med Chil 119(10):1115–1122PubMed Massardo L, Martinez ME, Baro M et al (1991) Infections in systemic lupus erythematosus. Rev Med Chil 119(10):1115–1122PubMed
3.
Zurück zum Zitat Oh HM, Chng HH, Boey ML, Feng PH (1993) Infections in systemic lupus erythematosus. Singapore Med J 34(5):406–408PubMed Oh HM, Chng HH, Boey ML, Feng PH (1993) Infections in systemic lupus erythematosus. Singapore Med J 34(5):406–408PubMed
4.
Zurück zum Zitat Shyam C, Malaviya AN (1996) Infection-related morbidity in systemic lupus erythematosus: a clinico-epidemiological study from northern India. Rheumatol Int 16(1):1–3PubMedCrossRef Shyam C, Malaviya AN (1996) Infection-related morbidity in systemic lupus erythematosus: a clinico-epidemiological study from northern India. Rheumatol Int 16(1):1–3PubMedCrossRef
5.
Zurück zum Zitat Paton NI (1997) Infections in systemic lupus erythematosus patients. Ann Acad Med Singapore 26(5):694–700PubMed Paton NI (1997) Infections in systemic lupus erythematosus patients. Ann Acad Med Singapore 26(5):694–700PubMed
6.
Zurück zum Zitat Feuchtenberger M, Kleinert S, Schwab S et al (2011) Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study. Rheumatol Int 32(6):1533–1539PubMedCrossRef Feuchtenberger M, Kleinert S, Schwab S et al (2011) Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study. Rheumatol Int 32(6):1533–1539PubMedCrossRef
7.
Zurück zum Zitat Fahy WA, Farnworth E, Yeldrem KP et al (2006) Pneumococcal and influenza vaccination in patients with rheumatic conditions and receiving DMARD therapy. Rheumatology (Oxford) 45(7):912–913 Fahy WA, Farnworth E, Yeldrem KP et al (2006) Pneumococcal and influenza vaccination in patients with rheumatic conditions and receiving DMARD therapy. Rheumatology (Oxford) 45(7):912–913
8.
Zurück zum Zitat Pradeep J, Watts R, Clunie G (2007) Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 66(6):837–838PubMedCrossRef Pradeep J, Watts R, Clunie G (2007) Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 66(6):837–838PubMedCrossRef
9.
Zurück zum Zitat Koutsogeorgopoulou L, Antoniadis C, Vassilopoulos D, Kassimos D (2009) Preventive influenza vaccination for patients with rheumatoid arthritis. A need for an international campaign. Clin Rheumatol 28(1):103–104PubMedCrossRef Koutsogeorgopoulou L, Antoniadis C, Vassilopoulos D, Kassimos D (2009) Preventive influenza vaccination for patients with rheumatoid arthritis. A need for an international campaign. Clin Rheumatol 28(1):103–104PubMedCrossRef
10.
Zurück zum Zitat Stojanovich L (2006) Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Clin Dev Immunol 13(2–4):373–375 Stojanovich L (2006) Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Clin Dev Immunol 13(2–4):373–375
11.
Zurück zum Zitat Duchet-Niedziolka P, Launay O, Coutsinos Z et al (2009) Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi survey. Vaccine 27(10):1523–1529PubMedCrossRef Duchet-Niedziolka P, Launay O, Coutsinos Z et al (2009) Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi survey. Vaccine 27(10):1523–1529PubMedCrossRef
12.
Zurück zum Zitat Heijstek MW, Pileggi GC, Zonneveld-Huijssoon E et al (2007) Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis. Ann Rheum Dis 66(10):1384–1387PubMedCrossRef Heijstek MW, Pileggi GC, Zonneveld-Huijssoon E et al (2007) Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis. Ann Rheum Dis 66(10):1384–1387PubMedCrossRef
13.
Zurück zum Zitat Borte S, Liebert UG, Borte M, Sack U (2009) Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology (Oxford) 48(2):144–148 Borte S, Liebert UG, Borte M, Sack U (2009) Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology (Oxford) 48(2):144–148
14.
Zurück zum Zitat Mota LM, Oliveira AC, Lima RA et al (2009) Vaccination against yellow fever among patients on immunosuppressors with diagnoses of rheumatic diseases. Rev Soc Bras Med Trop 42(1):23–27PubMedCrossRef Mota LM, Oliveira AC, Lima RA et al (2009) Vaccination against yellow fever among patients on immunosuppressors with diagnoses of rheumatic diseases. Rev Soc Bras Med Trop 42(1):23–27PubMedCrossRef
15.
Zurück zum Zitat Harpaz R, Ortega-Sanchez IR, Seward JF (2008) Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 57(RR-5):1–30 Harpaz R, Ortega-Sanchez IR, Seward JF (2008) Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 57(RR-5):1–30
16.
Zurück zum Zitat Elkayam O, Amir S, Mendelson E et al (2011) Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases. Arthritis Care Res (Hoboken) 63:1062–1067CrossRef Elkayam O, Amir S, Mendelson E et al (2011) Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases. Arthritis Care Res (Hoboken) 63:1062–1067CrossRef
17.
Zurück zum Zitat Evison J, Farese S, Seitz M et al (2009) Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Clin Infect Dis 48(10):1402–1412PubMedCrossRef Evison J, Farese S, Seitz M et al (2009) Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Clin Infect Dis 48(10):1402–1412PubMedCrossRef
18.
Zurück zum Zitat Holvast A, Huckriede A, Wilschut J et al (2006) Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 65(7):913–918PubMedCrossRef Holvast A, Huckriede A, Wilschut J et al (2006) Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 65(7):913–918PubMedCrossRef
19.
Zurück zum Zitat Moberley SA, Holden J, Tatham DP, Andrews RM (2008) Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev (1):CD000422 Moberley SA, Holden J, Tatham DP, Andrews RM (2008) Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev (1):CD000422
20.
Zurück zum Zitat Centers for Disease Control CDC (2008) Progress in introduction of pneumococcal conjugate vaccine – worldwide, 2000–2008. MMWR Morb Mortal Wkly Rep 57(42):1148–1151 Centers for Disease Control CDC (2008) Progress in introduction of pneumococcal conjugate vaccine – worldwide, 2000–2008. MMWR Morb Mortal Wkly Rep 57(42):1148–1151
21.
Zurück zum Zitat Metlay JP, Fishman NO, Joffe M, Edelstein PH (2006) Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine 24(4):468–475PubMedCrossRef Metlay JP, Fishman NO, Joffe M, Edelstein PH (2006) Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine 24(4):468–475PubMedCrossRef
22.
Zurück zum Zitat Carvalho JF de, Pereira RM, Shoenfeld Y (2008) Systemic polyarteritis nodosa following hepatitis B vaccination. Eur J Intern Med 19(8):575–578PubMedCrossRef Carvalho JF de, Pereira RM, Shoenfeld Y (2008) Systemic polyarteritis nodosa following hepatitis B vaccination. Eur J Intern Med 19(8):575–578PubMedCrossRef
23.
24.
Zurück zum Zitat Elkayam O, Yaron M, Caspi D (2002) Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis. Ann Rheum Dis 61(7):623–625PubMedCrossRef Elkayam O, Yaron M, Caspi D (2002) Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis. Ann Rheum Dis 61(7):623–625PubMedCrossRef
25.
Zurück zum Zitat Mast EE, Weinbaum CM, Fiore AE et al (2006) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 55(RR-16):1–33 Mast EE, Weinbaum CM, Fiore AE et al (2006) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 55(RR-16):1–33
26.
Zurück zum Zitat Dengler TJ, Zimmermann R, Meyer J et al (1999) Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients. Vaccine 17(7–8):867–874 Dengler TJ, Zimmermann R, Meyer J et al (1999) Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients. Vaccine 17(7–8):867–874
27.
Zurück zum Zitat Nath R, Mant C, Luxton J et al (2007) High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthritis Rheum 57(4):619–625PubMedCrossRef Nath R, Mant C, Luxton J et al (2007) High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthritis Rheum 57(4):619–625PubMedCrossRef
28.
Zurück zum Zitat Mok CC, Ho LY, Fong LS, To CH (2012) Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study. Ann Rheum Dis [Epub ahead of print] Mok CC, Ho LY, Fong LS, To CH (2012) Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study. Ann Rheum Dis [Epub ahead of print]
29.
Zurück zum Zitat Wiese-Posselt M, Hellenbrand W (2010) Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation. Euro Surveill 15(16)pii:19548PubMed Wiese-Posselt M, Hellenbrand W (2010) Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation. Euro Surveill 15(16)pii:19548PubMed
30.
Zurück zum Zitat Geier DA, King PG, Sykes LK, Geier MR (2008) RotaTeq vaccine adverse events and policy considerations. Med Sci Monit 14(3):H9–H16 Geier DA, King PG, Sykes LK, Geier MR (2008) RotaTeq vaccine adverse events and policy considerations. Med Sci Monit 14(3):H9–H16
31.
Zurück zum Zitat Roux A de, Schmole-Thoma B, Siber GR et al (2008) Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 46(7):1015–1023PubMedCrossRef Roux A de, Schmole-Thoma B, Siber GR et al (2008) Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 46(7):1015–1023PubMedCrossRef
32.
Zurück zum Zitat Roux A de, Marx A, Burkhardt O et al (2006) Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients. Vaccine 24(10):1537–1542PubMedCrossRef Roux A de, Marx A, Burkhardt O et al (2006) Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients. Vaccine 24(10):1537–1542PubMedCrossRef
33.
Zurück zum Zitat Kapetanovic MC, Saxne T, Sjoholm A et al (2006) Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 45(1):106–111 Kapetanovic MC, Saxne T, Sjoholm A et al (2006) Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 45(1):106–111
34.
Zurück zum Zitat Fomin I, Caspi D, Levy V et al (2006) Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 65(2):191–194PubMedCrossRef Fomin I, Caspi D, Levy V et al (2006) Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 65(2):191–194PubMedCrossRef
35.
Zurück zum Zitat Mazzone PJ, Mossad SB, Mawhorter SD et al (2001) The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J 18(6):971–976PubMedCrossRef Mazzone PJ, Mossad SB, Mawhorter SD et al (2001) The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J 18(6):971–976PubMedCrossRef
36.
Zurück zum Zitat Versluis DJ, Beyer WE, Masurel N et al (1986) Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 42(4):376–379PubMedCrossRef Versluis DJ, Beyer WE, Masurel N et al (1986) Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 42(4):376–379PubMedCrossRef
37.
Zurück zum Zitat Dengler TJ, Strnad N, Buhring I et al (1998) Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 66(10):1340–1347PubMedCrossRef Dengler TJ, Strnad N, Buhring I et al (1998) Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 66(10):1340–1347PubMedCrossRef
38.
Zurück zum Zitat Abu-Shakra M, Press J, Varsano N et al (2002) Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 29(12):2555–2557PubMed Abu-Shakra M, Press J, Varsano N et al (2002) Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 29(12):2555–2557PubMed
39.
Zurück zum Zitat Battafarano DF, Battafarano NJ, Larsen L et al (1998) Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 41(10):1828–1834PubMedCrossRef Battafarano DF, Battafarano NJ, Larsen L et al (1998) Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 41(10):1828–1834PubMedCrossRef
40.
Zurück zum Zitat Salles MJ, Sens YA, Boas LS, Machado CM (2010) Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs. Clin Transplant 24(1): E17–E23PubMedCrossRef Salles MJ, Sens YA, Boas LS, Machado CM (2010) Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs. Clin Transplant 24(1): E17–E23PubMedCrossRef
41.
Zurück zum Zitat Lipnick RN, Karsh J, Stahl NI et al (1985) Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives. J Rheumatol 12(6):1118–1121PubMed Lipnick RN, Karsh J, Stahl NI et al (1985) Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives. J Rheumatol 12(6):1118–1121PubMed
42.
Zurück zum Zitat Kaine JL, Kivitz AJ, Birbara C, Luo AY (2007) Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol 34(2):272–279PubMed Kaine JL, Kivitz AJ, Birbara C, Luo AY (2007) Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol 34(2):272–279PubMed
43.
Zurück zum Zitat Mease PJ, Ritchlin CT, Martin RW et al (2004) Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol 31:1356–1361PubMed Mease PJ, Ritchlin CT, Martin RW et al (2004) Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol 31:1356–1361PubMed
44.
Zurück zum Zitat Del PF, Lagana B, Biselli R et al (2006) Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 24(16):3217–3223CrossRef Del PF, Lagana B, Biselli R et al (2006) Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 24(16):3217–3223CrossRef
45.
Zurück zum Zitat Keshtkar-Jahromi M, Argani H, Rahnavardi M et al (2008) Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial. Am J Nephrol 28(4):654–660PubMedCrossRef Keshtkar-Jahromi M, Argani H, Rahnavardi M et al (2008) Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial. Am J Nephrol 28(4):654–660PubMedCrossRef
46.
Zurück zum Zitat Rentenaar RJ, Diepen FN van, Meijer RT et al (2002) Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo. Kidney Int 62(1):319–328PubMedCrossRef Rentenaar RJ, Diepen FN van, Meijer RT et al (2002) Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo. Kidney Int 62(1):319–328PubMedCrossRef
47.
Zurück zum Zitat Kapetanovic MC, Saxne T, Nilsson JA, Geborek P (2007) Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford) 46(4):608–611 Kapetanovic MC, Saxne T, Nilsson JA, Geborek P (2007) Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford) 46(4):608–611
48.
Zurück zum Zitat Visvanathan S, Keenan GF, Baker DG et al (2007) Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J Rheumatol 34(5):952–957PubMed Visvanathan S, Keenan GF, Baker DG et al (2007) Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J Rheumatol 34(5):952–957PubMed
49.
Zurück zum Zitat Gelinck LB, Bijl AE van der, Beyer WE et al (2008) The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis 67(5):713–716PubMedCrossRef Gelinck LB, Bijl AE van der, Beyer WE et al (2008) The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis 67(5):713–716PubMedCrossRef
50.
Zurück zum Zitat Elkayam O, Bashkin A, Mandelboim M et al (2009) The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 39(6):442–447PubMedCrossRef Elkayam O, Bashkin A, Mandelboim M et al (2009) The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 39(6):442–447PubMedCrossRef
51.
Zurück zum Zitat Gelinck LB, Teng YK, Rimmelzwaan GF et al (2007) Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis 66(10):1402–1403PubMedCrossRef Gelinck LB, Teng YK, Rimmelzwaan GF et al (2007) Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis 66(10):1402–1403PubMedCrossRef
52.
Zurück zum Zitat Albert D, Dunham J, Khan S et al (2008) Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus. Ann Rheum Dis 67(12):1724–1731PubMedCrossRef Albert D, Dunham J, Khan S et al (2008) Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus. Ann Rheum Dis 67(12):1724–1731PubMedCrossRef
53.
Zurück zum Zitat Horwitz SM, Negrin RS, Blume KG et al (2004) Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Blood 103(3):777–783PubMedCrossRef Horwitz SM, Negrin RS, Blume KG et al (2004) Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Blood 103(3):777–783PubMedCrossRef
54.
Zurück zum Zitat Bearden CM, Agarwal A, Book BK et al (2005) Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174. Am J Transplant 5(1):50–57PubMedCrossRef Bearden CM, Agarwal A, Book BK et al (2005) Rituximab inhibits the in vivo primary and secondary antibody response to a neoantigen, bacteriophage phiX174. Am J Transplant 5(1):50–57PubMedCrossRef
55.
Zurück zum Zitat Kolk LE van der, Baars JW, Prins MH, Oers MH van (2002) Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood 100(6):2257–2259PubMed Kolk LE van der, Baars JW, Prins MH, Oers MH van (2002) Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood 100(6):2257–2259PubMed
56.
Zurück zum Zitat Bingham CO III, Looney RJ, Deodhar A et al (2010) Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum 62(1):64–74PubMedCrossRef Bingham CO III, Looney RJ, Deodhar A et al (2010) Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum 62(1):64–74PubMedCrossRef
57.
Zurück zum Zitat van Assen S, Holvast A, Benne CA et al (2010) Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum 62(1):75–81CrossRef van Assen S, Holvast A, Benne CA et al (2010) Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum 62(1):75–81CrossRef
58.
Zurück zum Zitat Edwards JC, Szczepanski L, Szechinski J et al (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350(25):2572–2581PubMedCrossRef Edwards JC, Szczepanski L, Szechinski J et al (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350(25):2572–2581PubMedCrossRef
59.
Zurück zum Zitat Cambridge G, Leandro MJ, Teodorescu M et al (2006) B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum 54(11):3612–3622PubMedCrossRef Cambridge G, Leandro MJ, Teodorescu M et al (2006) B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum 54(11):3612–3622PubMedCrossRef
60.
Zurück zum Zitat Vallerskog T, Gunnarsson I, Widhe M et al (2007) Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol 122(1):62–74PubMedCrossRef Vallerskog T, Gunnarsson I, Widhe M et al (2007) Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol 122(1):62–74PubMedCrossRef
61.
Zurück zum Zitat Tay L, Leon F, Vratsanos G et al (2007) Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects. Arthritis Res Ther 9(2):R38PubMedCrossRef Tay L, Leon F, Vratsanos G et al (2007) Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects. Arthritis Res Ther 9(2):R38PubMedCrossRef
62.
Zurück zum Zitat Mori S, Ueki Y, Akeda Y et al (2013) Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy. Ann Rheum Dis 72(8):1362–1366PubMedCrossRef Mori S, Ueki Y, Akeda Y et al (2013) Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy. Ann Rheum Dis 72(8):1362–1366PubMedCrossRef
63.
Zurück zum Zitat Mori S, Ueki Y, Hirakata N et al (2012) Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis. Ann Rheum Dis 71(12):2006–2010PubMedCrossRef Mori S, Ueki Y, Hirakata N et al (2012) Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis. Ann Rheum Dis 71(12):2006–2010PubMedCrossRef
64.
Zurück zum Zitat Elkayam O, Caspi D, Reitblatt T et al (2004) The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 33:283–288PubMedCrossRef Elkayam O, Caspi D, Reitblatt T et al (2004) The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 33:283–288PubMedCrossRef
65.
Zurück zum Zitat Williams GW, Steinberg AD, Reinertsen JL et al (1978) Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Ann Intern Med 88(6):729–734PubMedCrossRef Williams GW, Steinberg AD, Reinertsen JL et al (1978) Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Ann Intern Med 88(6):729–734PubMedCrossRef
66.
Zurück zum Zitat Brodman R, Gilfillan R, Glass D, Schur PH (1978) Influenzal vaccine response in systemic lupus erythematosus. Ann Intern Med 88(6):735–740PubMedCrossRef Brodman R, Gilfillan R, Glass D, Schur PH (1978) Influenzal vaccine response in systemic lupus erythematosus. Ann Intern Med 88(6):735–740PubMedCrossRef
67.
Zurück zum Zitat Louie JS, Nies KM, Shoji KT et al (1978) Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Intern Med 88(6):790–792PubMedCrossRef Louie JS, Nies KM, Shoji KT et al (1978) Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Intern Med 88(6):790–792PubMedCrossRef
68.
Zurück zum Zitat Ristow SC, Douglas RG Jr, Condemi JJ (1978) Influenza vaccination of patients with systemic lupus erythematosus. Ann Intern Med 88(6):786–789PubMedCrossRef Ristow SC, Douglas RG Jr, Condemi JJ (1978) Influenza vaccination of patients with systemic lupus erythematosus. Ann Intern Med 88(6):786–789PubMedCrossRef
69.
Zurück zum Zitat Herron A, Dettleff G, Hixon B et al (1979) Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. JAMA 242(1):53–56PubMedCrossRef Herron A, Dettleff G, Hixon B et al (1979) Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. JAMA 242(1):53–56PubMedCrossRef
70.
Zurück zum Zitat Klippel JH, Karsh J, Stahl NI et al (1979) A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum 22:1321–1325PubMedCrossRef Klippel JH, Karsh J, Stahl NI et al (1979) A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum 22:1321–1325PubMedCrossRef
71.
Zurück zum Zitat Elkayam O, Paran D, Burke M et al (2005) Pneumococcal vaccination of patients with systemic lupus erythematosus: effects on generation of autoantibodies. Autoimmunity 38(7):493–496PubMedCrossRef Elkayam O, Paran D, Burke M et al (2005) Pneumococcal vaccination of patients with systemic lupus erythematosus: effects on generation of autoantibodies. Autoimmunity 38(7):493–496PubMedCrossRef
72.
Zurück zum Zitat Kuruma KA, Borba EF, Lopes MH et al (2007) Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus. Lupus 16(5):350–354PubMedCrossRef Kuruma KA, Borba EF, Lopes MH et al (2007) Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus. Lupus 16(5):350–354PubMedCrossRef
73.
Zurück zum Zitat Setti M, Fenoglio D, Ansaldi F et al (2009) Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients. Vaccine 27(25–26):3367–3372 Setti M, Fenoglio D, Ansaldi F et al (2009) Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients. Vaccine 27(25–26):3367–3372
74.
Zurück zum Zitat Mader R, Narendran A, Lewtas J et al (1993) Systemic vasculitis following influenza vaccination – report of 3 cases and literature review. J Rheumatol 20(8):1429–1431PubMed Mader R, Narendran A, Lewtas J et al (1993) Systemic vasculitis following influenza vaccination – report of 3 cases and literature review. J Rheumatol 20(8):1429–1431PubMed
75.
Zurück zum Zitat Schattner A (2005) Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 23(30):3876–3886PubMedCrossRef Schattner A (2005) Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 23(30):3876–3886PubMedCrossRef
76.
Zurück zum Zitat Holvast A, Stegeman CA, Benne CA et al (2009) Wegener’s granulomatosis patients show an adequate antibody response to influenza vaccination. Ann Rheum Dis 68(6):873–878PubMedCrossRef Holvast A, Stegeman CA, Benne CA et al (2009) Wegener’s granulomatosis patients show an adequate antibody response to influenza vaccination. Ann Rheum Dis 68(6):873–878PubMedCrossRef
77.
Zurück zum Zitat Stassen PM, Sanders JS, Kallenberg CG, Stegeman CA (2008) Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 23(2):654–658PubMedCrossRef Stassen PM, Sanders JS, Kallenberg CG, Stegeman CA (2008) Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 23(2):654–658PubMedCrossRef
78.
Zurück zum Zitat Sahin N, Salli A, Enginar AU, Ugurlu H (2009) Reactive arthritis following tetanus vaccination: a case report. Mod Rheumatol 19(2):209–211PubMedCrossRef Sahin N, Salli A, Enginar AU, Ugurlu H (2009) Reactive arthritis following tetanus vaccination: a case report. Mod Rheumatol 19(2):209–211PubMedCrossRef
79.
Zurück zum Zitat Gross K, Combe C, Kruger K, Schattenkirchner M (1995) Arthritis after hepatitis B vaccination. Report of three cases. Scand J Rheumatol 24(1):50–52PubMedCrossRef Gross K, Combe C, Kruger K, Schattenkirchner M (1995) Arthritis after hepatitis B vaccination. Report of three cases. Scand J Rheumatol 24(1):50–52PubMedCrossRef
80.
Zurück zum Zitat Assen S van, Agmon-Levin N, Elkayam O et al (2011) EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 70:414–422PubMedCrossRef Assen S van, Agmon-Levin N, Elkayam O et al (2011) EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 70:414–422PubMedCrossRef
Metadaten
Titel
Impfung bei erwachsenen Patienten mit chronisch entzündlichen rheumatischen Erkrankungen
verfasst von
Dr. S. Goldacker
A.M. Gause
K. Warnatz
Kommission Pharmakotherapie der DGRh
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Zeitschrift für Rheumatologie / Ausgabe 7/2013
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI
https://doi.org/10.1007/s00393-013-1155-4

Weitere Artikel der Ausgabe 7/2013

Zeitschrift für Rheumatologie 7/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.